Severe Impaired Deambulation in a Patient with Vitamin D and Mineral Deficiency Due to Exocrine Pancreatic Insufficiency

  • Anton Tedja Christensen Medical Department; Viborg Regional Hospital; 8800 Viborg; Denmark
  • Torben Østergård
  • Vibeke Andersen
Keywords: Mobility Limitation, Muscle Weakness, Pancreas, Phosphorus, Vitamin D Deficiency

Abstract

Context Skeletal muscle weakness and impaired gait function are common risk factors for disease and even death. Therefore, identification of the modifiable causes of skeletal muscle weakness should have high priority. Knowledge regarding optimal vitamin D treatment in cases of pancreatic insufficiency is scarce. Case report We report a case of a slow decrease in ability to walk distances more than 100 m during the previous 6 months. Low exocrine pancreatic function resulting in phosphorus, magnesium and vitamin D deficiency was found. Medical treatment with peroral pancreatic enzymes, phosphorus, magnesium and i.m. injections of ergocalciferol (vitamin D2) was initiated. Gait function gradually increased to a walking distance of 1,500-3,000 m along with the normalization of the vitamin D and mineral blood levels. Conclusions Vitamin D deficiency due to exocrine pancreatic insufficiency should be kept in mind as one of the reasons for impaired gait and skeletal muscle weakness.

Downloads

Download data is not yet available.

References

Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009; 13:708-12. [PMID 19657554]

Blain H, Carriere I, Sourial N, Berard C, Favier F, Colvez A, Bergman H. Balance and walking speed predict subsequent 8-year mortality independently of current and intermediate events in well-functioning women aged 75 years and older. J Nutr Health Aging 2010; 14:595-600. [PMID 20818476]

Teichmann J, Mann ST, Stracke H, Lange U, Hardt PD, Bretzel RG, Klör HU. Parathormone levels and Vitamin D metabolism in female patients with various grades of fecal elastase 1 deficiency. Eur J Med Res 2008; 13:563-7. [PMID 19073396]

Ceglia L. Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 2009; 12:628-33. [PMID 19770647]

Teichmann J, Mann ST, Stracke H, Lange U, Hardt PD, Klör HU, Bretzel RG. Alterations of vitamin D3 metabolism in young women with various grades of chronic pancreatitis. Eur J Med Res 2007; 12:347-50. [PMID 17933711]

Ferguson JH, Chang AB. Vitamin D supplementation for cystic fibrosis. Cochrane Database Syst Rev 2009; 4:CD007298. [PMID 19821402]

Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 2009; 38:149-53. [PMID 18991184]

Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010; 340:b5664. [PMID 20064851]

van den Bergh JP, Bours SP, van Geel TA, Geusens PP. Optimal use of vitamin D when treating osteoporosis. Curr Osteoporos Rep 2011; 9:36-42. [PMID 21113692]

Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007; 55:234-9. [PMID 17302660]

Schubert L, DeLuca HF. Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 2010; 500:157-61. [PMID 20515645]

Plasma values of 25-hydroxy vitamin D2+D3 for a patient with severe impaired walking function due to pancreatic insufficiency
Published
2011-08-10
How to Cite
ChristensenA., ØstergårdT., & AndersenV. (2011). Severe Impaired Deambulation in a Patient with Vitamin D and Mineral Deficiency Due to Exocrine Pancreatic Insufficiency. JOP. Journal of the Pancreas, 12(5), 482-484. https://doi.org/10.6092/1590-8577/452